ULTRAGENYX PHARMACEUTICAL INC. Shares Outstanding (Cover Page)
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Shares Outstanding (Cover Page) of 98.59 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 98.59M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 98.49M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 96.63M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 96.48M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 98.59M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 98.49M shares 10-Q · filed 2026-05-06 |
| 2026-02-13 | 96.63M shares 10-K · filed 2026-02-18 |
| 2025-10-30 | 96.48M shares 10-Q · filed 2025-11-05 |
| 2025-07-31 | 96.37M shares 10-Q · filed 2025-08-06 |
| 2025-05-01 | 94.54M shares 10-Q · filed 2025-05-07 |
| 2025-02-13 | 92.50M shares 10-K · filed 2025-02-19 |
| 2024-10-31 | 92.34M shares 10-Q · filed 2024-11-06 |
| 2024-07-29 | 92.17M shares 10-Q · filed 2024-08-02 |
| 2024-04-26 | 83.13M shares 10-Q · filed 2024-05-03 |
| 2024-02-15 | 82.34M shares 10-K · filed 2024-02-21 |
| 2023-10-30 | 82.11M shares 10-Q · filed 2023-11-03 |
| 2023-07-31 | 71.49M shares 10-Q · filed 2023-08-04 |
| 2023-05-01 | 70.81M shares 10-Q · filed 2023-05-05 |
| 2023-02-13 | 70.22M shares 10-K · filed 2023-02-17 |
| 2022-10-28 | 70.11M shares 10-Q · filed 2022-11-03 |
| 2022-07-25 | 70.04M shares 10-Q · filed 2022-07-29 |
| 2022-05-02 | 69.93M shares 10-Q · filed 2022-05-06 |
| 2022-02-10 | 69.38M shares 10-K · filed 2022-02-15 |
| 2021-10-28 | 68.16M shares 10-Q · filed 2021-11-03 |
| 2021-07-28 | 67.84M shares 10-Q · filed 2021-08-03 |
| 2021-04-30 | 67.48M shares 10-Q · filed 2021-05-05 |
| 2021-02-08 | 66.95M shares 10-K · filed 2021-02-12 |
| 2020-10-22 | 61.04M shares 10-Q · filed 2020-10-27 |
| 2020-07-27 | 60.59M shares 10-Q · filed 2020-07-30 |
| 2020-05-01 | 59.75M shares 10-Q · filed 2020-05-07 |
| 2020-02-10 | 57.89M shares 10-K · filed 2020-02-14 |
| 2019-10-31 | 57.77M shares 10-Q · filed 2019-11-06 |
| 2019-07-26 | 57.69M shares 10-Q · filed 2019-08-02 |
| 2019-05-01 | 57.47M shares 10-Q · filed 2019-05-07 |
| 2019-02-14 | 51.28M shares 10-K · filed 2019-02-20 |
| 2018-10-30 | 50.58M shares 10-Q · filed 2018-11-06 |
| 2018-07-30 | 50.18M shares 10-Q · filed 2018-08-03 |
| 2018-05-03 | 49.77M shares 10-Q · filed 2018-05-08 |
| 2018-02-15 | 49.61M shares 10-K · filed 2018-02-21 |
| 2017-10-30 | 42.59M shares 10-Q · filed 2017-11-03 |
| 2017-07-24 | 42.46M shares 10-Q · filed 2017-07-28 |
| 2017-05-01 | 42.31M shares 10-Q · filed 2017-05-05 |
| 2017-02-13 | 41.73M shares 10-K · filed 2017-02-17 |
| 2016-11-03 | 40.86M shares 10-Q · filed 2016-11-08 |
| 2016-08-03 | 39.44M shares 10-Q · filed 2016-08-09 |
| 2016-05-04 | 39.02M shares 10-Q · filed 2016-05-10 |
| 2016-02-19 | 38.98M shares 10-K · filed 2016-02-26 |
| 2015-11-04 | 38.83M shares 10-Q · filed 2015-11-10 |
| 2015-08-07 | 38.68M shares 10-Q · filed 2015-08-14 |
| 2015-05-06 | 35.90M shares 10-Q · filed 2015-05-12 |
| 2015-03-23 | 35.60M shares 10-K · filed 2015-03-27 |
| 2014-11-03 | 31.90M shares 10-Q · filed 2014-11-10 |
| 2014-08-06 | 31.70M shares 10-Q · filed 2014-08-11 |
| 2014-05-07 | 30.04M shares 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |